Jun 01, 2021 / 02:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst
Hi. Good morning, everybody. Thank you again for joining our Jefferies Virtual Healthcare Conference. I'm Dave Windley, Jefferies' health care equity research. I cover pharma services space, including contract research and contract development and manufacturing organizations. And in that space, Charles River Labs has been a very effective and positive grower in the space and developer of very broad, as Jim will tell you, very broad portfolio of products and services to that pharma biotech R&D space.
So CEO, Jim Foster, I should say, excuse me, Chairman, President and CEO, Jim Foster, is here to talk with me about Charles River Labs. I'm going to turn it over to him to lay some groundwork, and then we'll have Q&A.
Jim, thanks.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Thanks, Dave. Always a pleasure to talk to you. We had a really strong first quarter with sales grew 13%. Our operating margin was 20.7%
Charles River Laboratories International Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 01, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers